TWA
PAVMZ

TCI Wealth Advisors’s PAVmed Inc. Series Z Warrant PAVMZ Stock Holding History

TCI Wealth Advisors’s Portfolio PAVMZ Stock Details PAVMZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-700
Closed -$3K – 2604
2021
Q2 		$3K Sell
700
-500
-42% -$1.86K ﹤0.01% 1881
2021
Q1 		$3K Sell
1,200
-100
-8% -$201 ﹤0.01% 1615
2020
Q4 		$2K Buy
1,300
+500
+63% +$452 ﹤0.01% 1295
2020
Q3 		$1K Hold
800
– – ﹤0.01% 1466
2020
Q2 		$1K Buy
800
+500
+167% +$552 ﹤0.01% 1392
2020
Q1 		$0 Buy
+300
New +$239 ﹤0.01% 1802

Other funds holding PAVMZ

WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
LCS
Levin Capital Strategies New York $1.32B AUM 28.11% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TCI Wealth Advisors's PAVMZ Position: Q3 2021 in Review

TCI Wealth Advisors sold out of PAVmed Inc. Series Z Warrant (PAVMZ) in Q3 2021, closing a stake of 700 shares — an estimated $3K sold.

TCI Wealth Advisors first reported a position in PAVMZ in Q1 2020 and held it in 6 quarters. The position peaked at $3K in Q2 2021. 8 funds tracked by Wall St. Rank hold PAVMZ as of Q3 2021.

  • TCI Wealth Advisors reported no remaining PAVmed Inc. Series Z Warrant position as of Q3 2021 after selling out during the quarter.
  • TCI Wealth Advisors sold 700 PAVmed Inc. Series Z Warrant shares in Q3 2021, an estimated $3K.
  • TCI Wealth Advisors first reported a position in PAVmed Inc. Series Z Warrant in Q1 2020 and held it in 6 quarters.
  • TCI Wealth Advisors's PAVmed Inc. Series Z Warrant position peaked at $3K in Q2 2021.
  • 8 funds tracked by Wall St. Rank held PAVmed Inc. Series Z Warrant as of Q3 2021.

Based on TCI Wealth Advisors's 13F filing for Q3 2021, filed 29 Oct 2021.